More on IFRX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.53 |
|
|||
| Open | $1.51 | ||||
| 52 Wk High | $0.05 | ||||
| 52 Wk Low | $0.00 | ||||
| Day High | $1.59 | ||||
| Day Low | $1.48 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 889,583 | ||||
- Form 6-K InflaRx N.V. For: Oct 22
- InflaRx Highlights Izicopan’s Therapeutic Potential at Kidney Week 2026
- InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026
- InflaRx names Gabriela Alperovich as clinical development head
- InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development
- InflaRx to Host Virtual Capital Markets Day
- Needham Starts Inflarx NV (IFRX) at Buy
- InflaRx Announces Participation in September Investor Conferences
- Form SCHEDULE 13G InflaRx N.V. Filed by: Commodore Capital LP
- Form SCHEDULE 13G/A InflaRx N.V. Filed by: MONTANOVA CAPITAL, LLC
Entities mentioned with IFRX
- FDA | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- Raymond James | View Related Stories »
- Guggenheim | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
